Indicaciones de revascularización en angina estable

Grüentzig, 1979, Nonoperative dilation of coronary artery stenosis: percutaneous transluminal coronary angioplasty, N Engl J Med., 301, 61, 10.1056/NEJM197907123010201 Levine, 2016, Catheter Cardiovasc Interv., 87, 1001, 10.1002/ccd.26325 Seshadri, 2002, Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era, Circulation., 106, 2346, 10.1161/01.CIR.0000036595.92742.69 National, Institutes of Health, National Heart, Lung, and Blood Institute. Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda: National Heart, Lung, and Blood Institute; 2012. Montalescot, 2013, 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology, Eur Heart J., 34, 2949, 10.1093/eurheartj/eht296 Henderson, 2003, Seven- year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy, J Am Coll Cardiol., 42, 1161, 10.1016/S0735-1097(03)00951-3 Boden, 2007, Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med., 356, 1503, 10.1056/NEJMoa070829 Sedlis, 2015, Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease, N Engl J Med., 373, 1937, 10.1056/NEJMoa1505532 Fuster, 1992, The pathogenesis of coronary artery disease and acute coronary syndroms, N Engl J Med., 326, 242, 10.1056/NEJM199201233260406 Daly, 2005, The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologist in Europe: from the Euro Heart Survey of Stable Angina, Eur Heart J., 26, 996, 10.1093/eurheartj/ehi171 Pursnani, 2012, Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials, Circ Cardiovasc Interv., 5, 476, 10.1161/CIRCINTERVENTIONS.112.970954 Windecker, 2014, Eur Heart J., 35, 2541, 10.1093/eurheartj/ehu278 Sievers, 1993, Medical therapy versus PTCA: a prospective, randomized trial in patients with asymptomatic coronary single-vessel disease (abstr), Circulation., 88, I297 Hartigan, 1998, Am J Cardiol., 82, 1445, 10.1016/S0002-9149(98)00685-7 Pitt, 1999, Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease, Atorvastatin versus Revascularization Treatment Investigators, N Engl J Med., 341, 70, 10.1056/NEJM199907083410202 Shaw, 2008, Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy, Circulation., 117, 1283, 10.1161/CIRCULATIONAHA.107.743963 Frye, 2009, A randomized trial of therapies for type 2 diabetes and coronary artery disease, N Engl J Med., 360, 2503, 10.1056/NEJMoa0805796 Bangalore, 2012, Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials, Circulation, 125, 2873, 10.1161/CIRCULATIONAHA.112.097014 Bangalore, 2013, Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis, BMJ., 347, f6625, 10.1136/bmj.f6625 McNeely, 2016, Trends in patient characteristics and outcomes of coronary artery bypass grafting in the 2000 to 2012 medicare population, Ann Thorac Surg., 102, 132, 10.1016/j.athoracsur.2016.01.016 Kapoor, 2008, Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery, JACC Cardiovasc Interv., 1, 483, 10.1016/j.jcin.2008.07.001 Aziz, 2007, Meta-analysis of minimally invasive internal thoracic artery bypass vs. percutaneous revascularisation for isolated lesions of the left anterior descending artery, BMJ., 334, 617, 10.1136/bmj.39106.476215.BE Morice, 2010, Circulation., 121, 2645, 10.1161/CIRCULATIONAHA.109.899211 Park, 2011, Randomized trial of stents vs. bypass surgery for left main coronary artery disease, N Engl J Med., 364, 1718, 10.1056/NEJMoa1100452 Stone, 2016, Everolimus-eluting stents or bypass surgery for left main coronary artery disease, N Engl J Med., 375, 2223, 10.1056/NEJMoa1610227 Mäkikallio, 2016, Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial, Lancet., 388, 2743, 10.1016/S0140-6736(16)32052-9 Serruys, 2009, Percutaneous coronary intervention vs. coronary-artery bypass grafting for severe coronary artery disease, N Engl J Med., 360, 961, 10.1056/NEJMoa0804626 Pijls, 2007, Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study, J Am Coll Cardiol., 49, 2105, 10.1016/j.jacc.2007.01.087 Tonino, 2009, Fractional flow reserve vs. angiography for guiding percutaneous coronary intervention, N Engl J Med., 360, 213, 10.1056/NEJMoa0807611 De Bruyne, 2012, Fractional flow reserve-guided PCI vs. medical therapy in stable coronary disease, N Engl J Med., 367, 991, 10.1056/NEJMoa1205361